Directory
>
Steve Kye
Steve Kye
Vice President, Clinical Development - Myelofibrosis and MDS | Karyopharm Therapeutics Inc.
Los Angeles, California, United States
Steve Kye
Summary
Steve Kye is a highly accomplished physician and drug developer with extensive experience in clinical development, particularly in the field of hematology and oncology. Currently serving as the Vice President of Clinical Development at Karyopharm Therapeutics, he has a proven track record in driving product development from concept to approval. With an MD and MPH, Steve combines clinical expertise with strategic thinking and strong leadership skills. His work spans various organizations, including AbbVie and Xencor, where he has led significant clinical trials and regulatory submissions. Steve is recognized for his ability to navigate complex regulatory environments and for his contributions to advancing treatments for heme malignancies. His passion for research is evident in his numerous publications, showcasing his dedication to improving patient outcomes through innovative therapies.
Steve Kye
Work Experience
Vice President, Clinical Development - Myelofibrosis and MDS at
Karyopharm Therapeutics Inc.
March 2023 - Present
Executive Medical Director, Clinical Development at
Xencor
October 2021 - March 2023
Head of Hematology and Cytokine Oncology Programs, Clinical Development at
Xencor
July 2022 - March 2023
Head of Hematology, Clinical Development at
Xencor
April 2022 - July 2022
Senior Medical Director, Hematology/Oncology Global Development at
AbbVie
September 2018 - October 2021
Venetoclax MDS Global Development Lead (GDL) at
AbbVie
June 2020 - October 2021
Medical Director, Clinical Development at
Acerta Pharma B.V. (A member of the AstraZeneca Group)
October 2017 - September 2018
Medical Director, Medical Affairs & Clinical Development at
ONO PHARMACEUTICAL CO., LTD.
May 2016 - October 2017
Medical Director / VP of Business Development at
Gencurix, Inc.
November 2015 - May 2016
Principal Medical Advisor, Medical Affairs and Clinical Development at
CJ헬스케어(CJ HealthCare Corp.)
December 2014 - November 2015
Senior Clinical Scientist at
Beckman Coulter Diagnostics
May 2013 - December 2014
Clinical Study/Research Project Manager at
Department of Veterans Affairs
November 2011 - April 2013
Postdoctoral Fellow at
UCLA Health
June 2009 - October 2011
Clinical Research Manager, Lung Cancer Chemoprevention at
UCLA Health
April 2008 - May 2009
Steve Kye
Education
Emory University, Master Of Public Health
January 1970 - January 1970
University of California, Irvine - The Paul Merage School of Business, Master Of Business Administration
January 1970 - January 1970
University of California, Los Angeles, Bachelors
January 1970 - January 1970
David Geffen School of Medicine at UCLA
January 1970 - January 1970
University of California, Irvine, Master Of Business Administration
January 1970 - January 1970
Seoul National University, Doctor Of Medicine
January 1970 - January 1970
University of California, Los Angeles, Bachelors
January 1970
Frequently Asked Questions about Steve Kye
What is Steve Kye email address?
Steve Kye's primary email address is ****@xencor.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Steve Kye work for?
Steve Kye is a Vice President, Clinical Development - Myelofibrosis and MDS at Karyopharm Therapeutics Inc., a company specializing in Biological products, except diagnostic.
Where Steve Kye graduated from?
Steve Kye holds a degree in Masters from Emory University.
How can I directly contact Steve Kye?
To contact Steve Kye directly, you can use the email address ****@xencor.com. Complete contact information is available upon registration with Muraena.
Who is Steve Kye?
Steve Kye is a highly accomplished physician and drug developer with extensive experience in clinical development, particularly in the field of hematology and oncology. Currently serving as the Vice President of Clinical Development at Karyopharm Therapeutics, he has a proven track record in driving product development from concept to approval. With an MD and MPH, Steve combines clinical expertise with strategic thinking and strong leadership skills. His work spans various organizations, including AbbVie and Xencor, where he has led significant clinical trials and regulatory submissions. Steve is recognized for his ability to navigate complex regulatory environments and for his contributions to advancing treatments for heme malignancies. His passion for research is evident in his numerous publications, showcasing his dedication to improving patient outcomes through innovative therapies.
Steve`s contact details
****@xencor.com
*********@abbvie.com
*********@abbott.com
****@beckmancoulter.com
*********@acerta-pharma.com
*****@ono.co.jp
****@cj.net
****@karyopharm.com
****@mednet.ucla.edu
******@gencurix.com
*********@va.gov
********@ucla.edu
Colleagues
Vice President, Data Sciences
Independent Board Director
Lecturer, Graduate Program (Regulatory Affairs)
Vice President Research & Translational Medicine
Vice President, Business Operations and Corporate Affairs
Executive Director - Head of Medical Strategy Global Medical and Scientific Affairs
Vice President of Market Access
Vice President, Clinical Pharmacology
Vice President, Program Lead - Oncology
Vice President, Regulatory Affairs